Estelamari Rodriguez, MD, MPH
Articles by Estelamari Rodriguez, MD, MPH

Patient Case 4: 50-Year-Old Woman Non-Smoker with Pleural Metastases
ByAlexander Spira, MD, PhD, FACP,Sandip Patel, MD,Estelamari Rodriguez, MD, MPH,Christine Bestvina, MD Estelamari Rodriguez, MD, MPH, presents a case of a 50-year-old African American woman, non-smoker, with pleural metastases; the panel discusses interstitial lung disease management, the use of antibody-drug conjugates, disease timing, and strategies for providing symptomatic relief, specifically considering drug holds if steroids only offer partial relief.

Patient Case 3: A 34-Year-Old Non-Smoker with Stage IIIA NSCLC
ByAlexander Spira, MD, PhD, FACP,Sandip Patel, MD,Estelamari Rodriguez, MD, MPH,Christine Bestvina, MD Christine Bestvina, MD, presents a case of a 34-year-old non-smoker diagnosed with Stage IIIA NSCLC after presenting with chest wall pain; the panel then explores their approaches to managing toxicities, including rashes and sores, by employing dose reductions and steroids to control adverse reactions.

Patient Case 2: A 45-Year-Old Man with NSCLC Stage IV with Bone and Liver Metastases
ByAlexander Spira, MD, PhD, FACP,Sandip Patel, MD,Estelamari Rodriguez, MD, MPH,Christine Bestvina, MD Alexander Spira, MD, PhD, FACP, presents a case of a 45-year-old male with stage IV NSCLC, bone and liver metastases, and an EGFR exon 20 insertion; the panel then discusses their approach to treating brain metastases using stereotactic radiosurgery radiation therapy.

Counseling Patients and Caregivers on NSCLC Treatment Toxicities
ByAlexander Spira, MD, PhD, FACP,Sandip Patel, MD,Estelamari Rodriguez, MD, MPH,Christine Bestvina, MD The panelists explore the importance of communicating with patients, nurses, and caregivers about potential adverse reactions and injection site reactions, while emphasizing the need to offer ongoing reassurance and support throughout the treatment journey.